MedPath

Effect of Simvastatin on recurrence of endometriosis

Phase 2
Conditions
Endometrium
Endometriosis.
Registration Number
IRCT201009123384N5
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
80
Inclusion Criteria

Patients who have laparoscopy and their histological result is endometriosis. Exclusion criteria: Patients who don’t like to do laparoscopy or take drug.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Recurrence of endometriosis. Timepoint: First & 6 months after treatment. Method of measurement: Laparoscopy.
Secondary Outcome Measures
NameTimeMethod
Severity of dyspareunia. Timepoint: the day after operation and one month after termination of medical treatment. Method of measurement: Visual Analog Scale.;Pelvic pain. Timepoint: the day after operation and one month after termination of medical treatment. Method of measurement: Visual Analog Scale.
© Copyright 2025. All Rights Reserved by MedPath